Albert G. White, III net worth and biography

Albert White, III Biography and Net Worth

Director of Evolus

Albert G. White III has served as a member of our board of directors since July 2024. Mr. White has served as President & Chief Executive Officer of The Cooper Companies, Inc., branded CooperCompanies (NASDAQ: COO), a leading global medical device company in contact lenses, fertility, and women’s health, since May 2018. Previously, he served as Chief Financial Officer from November 2016 until his appointment as CEO and he also served as Executive Vice President and Chief Strategy Officer, positions he held from December 2015 and July 2011, respectively. From August 2015 to May 2018, Mr. White also directed The Cooper Companies, Inc. women’s healthcare business and served as Chief Executive Officer of Cooper Medical Inc., the parent company to CooperSurgical. Previously, he served as Vice President, Investor Relations from November 2007 through March 2013 and as Vice President and Treasurer from April 2006 through December 2012. Prior to joining The Cooper Companies, Inc., Mr. White was a Director with KeyBanc Capital Markets for three years and held a number of leadership positions within KeyBank National Association over the prior eight years.

What is Albert G. White, III's net worth?: The estimated net worth of Albert G. White, III is at least $1.54 million as of September 5th, 2025. Mr. White, III owns 226,151 shares of Evolus stock worth more than $1,540,088 as of December 5th. This net worth estimate does not reflect any other investments that Mr. White, III may own. Learn More about Albert G. White, III's net worth.
How do I contact Albert G. White, III?: The corporate mailing address for Mr. White, III and other Evolus executives is 520 Newport Center Dr. Suite 1200, Newport Beach CA, 92660. Evolus can also be reached via phone at (949) 284-4555 and via email at [email protected]. Learn More on Albert G. White, III's contact information.
Has Albert G. White, III been buying or selling shares of Evolus?: Albert G. White, III has not been actively trading shares of Evolus during the last ninety days. Most recently, on Monday, June 9th, Albert G. White III bought 20,000 shares of Evolus stock. The stock was acquired at an average cost of $9.45 per share, with a total value of $189,000.00. Following the completion of the transaction, the director now directly owns 50,378 shares of the company's stock, valued at $476,072.10. Learn More on Albert G. White, III's trading history.
Who are Evolus' active insiders?: Evolus' insider roster includes Rui Avelar (Insider), David Gill (Director), David Gill (Director), Vikram Malik (Director), David Moatazedi (Insider), Albert White, III (Director), and Tomoko Yamagishi-Dressler (CMO). Learn More on Evolus' active insiders.
Are insiders buying or selling shares of Evolus?: During the last twelve months, Evolus insiders bought shares 2 times. They purchased a total of 50,000 shares worth more than $393,600.00. During the last twelve months, insiders at the sold shares 13 times. They sold a total of 223,706 shares worth more than $2,416,073.05. The most recent insider tranaction occured on August, 22nd when CMO Tomoko Yamagishi-Dressler sold 5,722 shares worth more than $42,972.22. Insiders at Evolus own 5.9% of the company. Learn More about insider trades at Evolus.
Information on this page was last updated on 8/22/2025.

Albert G. White, III Insider Trading History at Evolus

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
6/9/2025	Buy	20,000	$9.45	$189,000.00	50,378

Albert G. White, III Buying and Selling Activity at Evolus

Evolus Company Overview

Evolus, Inc., a performance beauty company, focuses on delivering products in the cash-pay aesthetic market in the United States, Canada, and Europe. The company offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. It also provides dermal filler products under the Estyme and Evolysse names. The company was incorporated in 2012 and is headquartered in Newport Beach, California.

Today's Range

Now: $6.81

$6.69

$6.85

50 Day Range

MA: $6.67

$5.99

$7.37

2 Week Range

Now: $6.81

$5.71

$17.12

Volume

541,556 shs

Average Volume

1,639,299 shs

Market Capitalization

$441.42 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.87